Cargando…

The community pharmacy setting for diabetes prevention: Views and perceptions of stakeholders

BACKGROUND: Diabetes prevention programmes delay or prevent the onset of type 2 diabetes in people with pre-diabetes. To increase accessibility, national guidelines recommend delivering diabetes prevention programmes in primary care settings, including community pharmacy. This study aimed to explore...

Descripción completa

Detalles Bibliográficos
Autores principales: Katangwe, Thando, Family, Hannah, Sokhi, Jeremy, Al-Jabr, Hiyam, Kirkdale, Charlotte L., Twigg, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6638927/
https://www.ncbi.nlm.nih.gov/pubmed/31318897
http://dx.doi.org/10.1371/journal.pone.0219686
_version_ 1783436376525504512
author Katangwe, Thando
Family, Hannah
Sokhi, Jeremy
Al-Jabr, Hiyam
Kirkdale, Charlotte L.
Twigg, Michael J.
author_facet Katangwe, Thando
Family, Hannah
Sokhi, Jeremy
Al-Jabr, Hiyam
Kirkdale, Charlotte L.
Twigg, Michael J.
author_sort Katangwe, Thando
collection PubMed
description BACKGROUND: Diabetes prevention programmes delay or prevent the onset of type 2 diabetes in people with pre-diabetes. To increase accessibility, national guidelines recommend delivering diabetes prevention programmes in primary care settings, including community pharmacy. This study aimed to explore the English community pharmacy setting as an option for delivering diabetes prevention services. METHODS: Two focus groups and nine semi-structured interviews were conducted with stakeholders including, community pharmacists, general practitioners and commissioners. The topic guide was framed using the COM-B theoretical model for behaviour change to elicit practitioners’ capability, opportunity and motivation to engage with providing or referring to community pharmacy diabetes prevention services. Data were analysed thematically, and barriers/facilitators mapped to the COM-B framework. RESULTS: Five themes were identified: ‘Pre-diabetes management and associated challenges’, ‘The community pharmacy setting’, ‘Awareness of community pharmacy services’, ‘Relationships and communication’ and ‘Delivery of community pharmacy services’. Community pharmacy was highlighted as an accessible setting for delivering screening and follow-on lifestyle interventions. Key factors for enhancing the capability of community pharmacy teams to deliver the interventions included training and appropriate use of skill mix. Delivering diabetes prevention services in collaboration with general practices was identified as key to the provision of integrated primary care services. Whilst financial incentives were identified as a motivating factor for delivery, service promotion to patients, public and healthcare professionals was perceived as crucial for enhancing engagement. CONCLUSIONS: This research highlights a role for community pharmacy in diabetes prevention. New service models should seek to integrate community pharmacy services in primary care to facilitate patient engagement and better communication with general practices.
format Online
Article
Text
id pubmed-6638927
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-66389272019-07-25 The community pharmacy setting for diabetes prevention: Views and perceptions of stakeholders Katangwe, Thando Family, Hannah Sokhi, Jeremy Al-Jabr, Hiyam Kirkdale, Charlotte L. Twigg, Michael J. PLoS One Research Article BACKGROUND: Diabetes prevention programmes delay or prevent the onset of type 2 diabetes in people with pre-diabetes. To increase accessibility, national guidelines recommend delivering diabetes prevention programmes in primary care settings, including community pharmacy. This study aimed to explore the English community pharmacy setting as an option for delivering diabetes prevention services. METHODS: Two focus groups and nine semi-structured interviews were conducted with stakeholders including, community pharmacists, general practitioners and commissioners. The topic guide was framed using the COM-B theoretical model for behaviour change to elicit practitioners’ capability, opportunity and motivation to engage with providing or referring to community pharmacy diabetes prevention services. Data were analysed thematically, and barriers/facilitators mapped to the COM-B framework. RESULTS: Five themes were identified: ‘Pre-diabetes management and associated challenges’, ‘The community pharmacy setting’, ‘Awareness of community pharmacy services’, ‘Relationships and communication’ and ‘Delivery of community pharmacy services’. Community pharmacy was highlighted as an accessible setting for delivering screening and follow-on lifestyle interventions. Key factors for enhancing the capability of community pharmacy teams to deliver the interventions included training and appropriate use of skill mix. Delivering diabetes prevention services in collaboration with general practices was identified as key to the provision of integrated primary care services. Whilst financial incentives were identified as a motivating factor for delivery, service promotion to patients, public and healthcare professionals was perceived as crucial for enhancing engagement. CONCLUSIONS: This research highlights a role for community pharmacy in diabetes prevention. New service models should seek to integrate community pharmacy services in primary care to facilitate patient engagement and better communication with general practices. Public Library of Science 2019-07-18 /pmc/articles/PMC6638927/ /pubmed/31318897 http://dx.doi.org/10.1371/journal.pone.0219686 Text en © 2019 Katangwe et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Katangwe, Thando
Family, Hannah
Sokhi, Jeremy
Al-Jabr, Hiyam
Kirkdale, Charlotte L.
Twigg, Michael J.
The community pharmacy setting for diabetes prevention: Views and perceptions of stakeholders
title The community pharmacy setting for diabetes prevention: Views and perceptions of stakeholders
title_full The community pharmacy setting for diabetes prevention: Views and perceptions of stakeholders
title_fullStr The community pharmacy setting for diabetes prevention: Views and perceptions of stakeholders
title_full_unstemmed The community pharmacy setting for diabetes prevention: Views and perceptions of stakeholders
title_short The community pharmacy setting for diabetes prevention: Views and perceptions of stakeholders
title_sort community pharmacy setting for diabetes prevention: views and perceptions of stakeholders
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6638927/
https://www.ncbi.nlm.nih.gov/pubmed/31318897
http://dx.doi.org/10.1371/journal.pone.0219686
work_keys_str_mv AT katangwethando thecommunitypharmacysettingfordiabetespreventionviewsandperceptionsofstakeholders
AT familyhannah thecommunitypharmacysettingfordiabetespreventionviewsandperceptionsofstakeholders
AT sokhijeremy thecommunitypharmacysettingfordiabetespreventionviewsandperceptionsofstakeholders
AT aljabrhiyam thecommunitypharmacysettingfordiabetespreventionviewsandperceptionsofstakeholders
AT kirkdalecharlottel thecommunitypharmacysettingfordiabetespreventionviewsandperceptionsofstakeholders
AT twiggmichaelj thecommunitypharmacysettingfordiabetespreventionviewsandperceptionsofstakeholders
AT katangwethando communitypharmacysettingfordiabetespreventionviewsandperceptionsofstakeholders
AT familyhannah communitypharmacysettingfordiabetespreventionviewsandperceptionsofstakeholders
AT sokhijeremy communitypharmacysettingfordiabetespreventionviewsandperceptionsofstakeholders
AT aljabrhiyam communitypharmacysettingfordiabetespreventionviewsandperceptionsofstakeholders
AT kirkdalecharlottel communitypharmacysettingfordiabetespreventionviewsandperceptionsofstakeholders
AT twiggmichaelj communitypharmacysettingfordiabetespreventionviewsandperceptionsofstakeholders